Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-Coronavirus Therapies to Prevent Progression of COVID-19, a Randomized Trial

NCT04324463 is registered in ClinicalTrials.gov with Population Health Research Institute as lead sponsor.

NCT NCT04324463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04324463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-Coronavirus Therapies to Prevent Progression of COVID-19, a Randomized Trial
Lead sponsor
Population Health Research Institute
Phase
Phase 3
Overall status
Completed
Start date
April 21, 2020
Completion date
December 30, 2022
Enrollment
6,667 (actual)
Sites
66

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus, severe acute respiratory syndrome